Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing

By HospiMedica International staff writers
Posted on 10 Nov 2026

Acute infectious gastroenteritis, caused by viral, bacterial, and parasitic pathogens, remains a significant global health concern that inflames the gastrointestinal tract. More...

Symptoms such as diarrhea, vomiting, fever, and abdominal pain are often nonspecific, making diagnostic testing critical, particularly for young children, older adults, and immunocompromised individuals. A newly authorized set of molecular panels now enhances detection of gastrointestinal pathogens, including norovirus, from a single sample in about one hour.

bioMérieux has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BioFire FilmArray Gastrointestinal 1.1 (GI1.1) Panel and the BioFire FilmArray Gastrointestinal 1.1 (GI1.1) Panel Mid. The GI1.1 Panel has also obtained CE marking under the European Union In Vitro Diagnostic Regulation (IVDR). The panels test for 22 and 11 of the most common bacteria, viruses, and parasites associated with gastroenteritis, respectively.

The PCR molecular panels are designed to detect pathogens directly from stool samples from individuals with signs or symptoms of gastrointestinal infection. The new versions include a redesigned norovirus GI/GII assay and a software-based improvement for Campylobacter detection, strengthening specificity and confidence in results. They are designed for use on the BioFire FilmArray 2.0 and Torch systems, require about two minutes of hands-on setup time, and have an approximate run time of about one hour.

The BioFire FilmArray GI1.1 Panel includes bacterial, viral, and parasitic targets, including Campylobacter, Clostridioides difficile, Salmonella, Norovirus GI/GII, Rotavirus A, Cryptosporidium, and Giardia lamblia. The GI1.1 Panel Mid includes selected bacterial targets, Norovirus GI/GII, and the parasites Cryptosporidium, Cyclospora cayetanensis, and Giardia lamblia. The GI1.1 Panel will be deployed across all regions, while the GI1.1 Panel Mid will initially be available in the United States.

“The regulatory authorizations of these enhanced gastrointestinal panels mark an important milestone in ensuring healthcare providers have access to the most up-to-date diagnostic tools to support patient care. This is particularly important for norovirus, which remains one of the most prevalent and disruptive causes of acute gastroenteritis, and can spread rapidly in communities and healthcare settings. By providing timely and reliable diagnostic information, these panels can help clinicians make informed decisions earlier, support infection control efforts, and ultimately improve the patient experience,” said Dr. Charles K. Cooper, Executive Vice President, Chief Medical Officer, bioMérieux.


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Vessel Sealing Instrument
ERGOseal
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.